Pancreatic Cancer Research

ResearcherHarbin Medical UniversityNo recent work listed

Qi Zhao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0011-1208; OpenAlex author ID A5102021979. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper

Papers 2

  1. IMB5036 inhibits human pancreatic cancer growth primarily through activating necroptosis. Co-author DOI 10.1111/bcpt.13694↗
  2. STAT1-mediated inhibition of FOXM1 enhances gemcitabine sensitivity in pancreatic cancer. Co-author DOI 10.1042/cs20180816↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yanbo Zheng · 1 shared paper, 2022 · strength 0.20
  2. Lijun Yang · 1 shared paper, 2022 · strength 0.20
  3. Chao Liu · 1 shared paper, 2019 · strength 0.08
  4. Jiaqi Shi · 1 shared paper, 2019 · strength 0.08
  5. Zengxun Li · 1 shared paper, 2019 · strength 0.08
  6. Lin Fang · 1 shared paper, 2019 · strength 0.08
  7. Changjie Lou · 1 shared paper, 2019 · strength 0.08
  8. Zhiwei Li · 1 shared paper, 2019 · strength 0.08
  9. Jie Lian · 1 shared paper, 2019 · strength 0.08
  10. Yanqiao Zhang · 1 shared paper, 2019 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.